Oxford Study: Risk of Heart Inflammation for Young People is Higher from Vaccine Than from Covid

A CDC panel is recommending a longer waiting period in between mRNA covid shots due to a reported spike in heart inflammation cases. This is a remarkable admission that the vaccines have an increased risk of side effects for millions of Americans.

“A wider gap between the first two doses of the mRNA Covid-19 vaccines could improve the shots’ effectiveness and help reduce the risk of a rare type of heart inflammation called myocarditis, experts told a Centers for Disease Control and Prevention advisory committee on Friday,” as NBC reported.

“Members of the group, the CDC’s Advisory Committee on Immunization Practices, largely supported extending the recommended interval between the first two doses of both the Pfizer-BioNTech and Moderna vaccines to eight weeks,” the report added.

The recommended adjustment of the CDC timeline is another tacit admission that the Covid mRNA shots had unforeseen side effects and were not properly tested in clinical trials. Furthermore, the full clinical data for the Pfizer vaccine has not yet been fully released. The FDA has also ‘fully authorized’ the Moderna mRNA shots, but has also provided the company with a liability shield.

An Oxford University study earlier showed that the risk of myocarditis, a form of heart inflammation, is greater from getting ‘vaccinated’ with the mRNA shots than from contracting the virus itself. The study was originally published in Nature in December.

“This is the largest study to date of acute cardiac outcomes after SARS-CoV-2 vaccination or infection, the first to compare the risk of cardiac events between different vaccine products and SARS-CoV2 infection and the first to investigate the association between cardiac events and the ChAdOx1 vaccine,” the study stated.

“Our findings are relevant to the public, clinicians and policy makers,” the researchers note. “First, there was an increase in the risk of myocarditis within a week of receiving the first dose of both adenovirus and mRNA vaccines, and a higher increased risk after the second dose of both mRNA vaccines.”

The study included a chart that demonstrated the higher incidence rate of myocarditis for those under 40 years old, particularly after a second Moderna mRNA shot.

“In under 40-year-old people… dose two of Moderna has exceeded the risk of myocarditis after infection with a second dose,” Dr. Vinay Prasad said about the study. “There have been many people who have been reluctant to take serious the risks of myocarditis after the Moderna product.”

“If you’re under 40 and if you pool men and women together, there is more myocarditis associated with dose two of Moderna than there is with an infection. That is a bombshell finding,” Dr. Prasad continued.

The Pentagon is also scrambling to bury a dataset that appeared to show an explosion of side effects in the U.S. military following its vaccine mandate. Meanwhile, a number of European countries have already paused the mRNA shots being administered to young people.

“The use of Moderna’s COVID-19 vaccine has been paused in Sweden, Denmark, Finland and Iceland for use in young people,” Reuters has noted.

In the United States, however, the CDC is recommending that children as young as 5 years old be vaccinated, despite healthy children under 18 years old having a statistical 100% survival rate for Covid-19.

Syndicated with licensed permission from Becker News. Follow Becker News on Telegram.